Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William C. Denby currently holds 108,750 shares of Adamis Pharmaceuticals Corp (ADMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William C. Denby has been a net seller of ADMP stock. They have purchased $22.6K and sold $5.0M worth of shares.
William C. Denby's most recent insider trade was on May 24, 2019, when they purchased 6,250 shares at $1.60 per share.
William C. Denby serves as Executive at Adamis Pharmaceuticals Corp (ADMP). They have executed 141 insider transactions totaling $5.0M over their tenure at the company.
William C. Denby holds the position of Executive at Adamis Pharmaceuticals Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
William C. Denby has shown a selling trading pattern, with $22.6K in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by William C. Denby was on Jan 2, 2014, when they sold $4.6M worth of SNTS shares. This transaction involved 145,015 shares at $32.00 per share.
William C. Denby currently owns 108,750 shares of Adamis Pharmaceuticals Corp (ADMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William C. Denby's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William C. Denby has 141 Form 4 filings on record as an insider at Adamis Pharmaceuticals Corp.
Set alerts for William C. Denby and 40,000+ other insiders.